Search -

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

Caitlin E. Cox

December 18, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Daily News

Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame?

Shelley Wood

June 11, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Michael O'Riordan

October 22, 2019

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

L.A. McKeown

August 04, 2016

Advertisement

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Fewer Diabetic Complications Seen When NOACs Given for AF

Even Low-Dose Steroids Increase the Risk of CVD

Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame?

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content